NLS Pharmaceutics News

20-F: Registration statement / Annual report / Transition report

SEC announcementMay 15 22:33 ET · Announcements

NLS Pharmaceutics Challenges Nasdaq Delisting

TipRanksApr 19 18:27 ET

Express News | NLS Pharmaceutics Announces Receipt of Staff Delisting Determination From Nasdaq; Intends to Request Hearing

Moomoo 24/7Apr 19 17:04 ET

NLS Pharmaceutics Ltd Strategizes for Growth

TipRanksApr 15 21:02 ET

Board Member Resigns From NLS Pharmaceutics Ltd.

TipRanksApr 8 16:58 ET

NLS Pharmaceutics Ltd. Announces New Warrant Issue

TipRanksMar 21 21:27 ET

XTL Biopharmaceuticals XTLB Term Sheet; NLS Pharmaceutics NLSP Offering and Licensing Deal

BioPharmCatalystMar 20 15:51 ET

NLS Pharmaceutics Ltd. Addresses Financial Claims

TipRanksMar 20 13:57 ET

Express News | NLS Pharmaceutics Announces $1.75M Registered Direct Offering Of 7M Shares At $0.25/Share

Moomoo 24/7Mar 20 13:49 ET

NLS Pharmaceutics Expands Neurological Therapy Options

TipRanksMar 20 10:28 ET

Express News | NLS Pharmaceutics Shares Are Trading Higher After the Company Announced an Exclusive Worldwide License Agreement With Aexon Labs, Which Grants the Company the Opportunity to Acquire Global Development and Commercialization Rights to Aexon's Dual Orexin Re

Moomoo 24/7Mar 20 08:35 ET

Express News | NLS Pharmaceutics Secures Exclusive Global License For Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform

Moomoo 24/7Mar 20 07:39 ET

NLS Pharmaceutics Extends Loan Maturity Date

TipRanksMar 20 06:57 ET

NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event

ZURICH, SWITZERLAND / ACCESSWIRE / March 14, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discove

AccesswireMar 14 08:00 ET

Express News | NLS Pharmaceutics Has Been Notified By The Listing Qualifications Department Of The Nasdaq Stock Market That The Company's Plan To Regain Compliance Submitted On February 23, 2024 Has Been Approved

Moomoo 24/7Mar 11 07:38 ET

Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance

Seeking AlphaMar 11 07:31 ET

Express News | NLS Pharmaceutics Says It Submited Plan To Regain Listing Compliance With Nasdaq

Moomoo 24/7Feb 23 07:45 ET

NLS Pharmaceutics Announced Nasdaq Letter Related To Continued Listing Requirements

NLS Pharmaceutics Announced Nasdaq Letter Related To Continued Listing Requirements

BenzingaJan 12 16:33 ET

NLS Pharmaceutics CEO Issues Letter to Shareholders

NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) today announces that its Chief Executive Officer, Alex Zwyer, has issued the following letter to shareholders.

AccesswireDec 29, 2023 16:30 ET

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks rose Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%. The iShares Biotechnology ETF (IBB) was up 0.7%. In corpora

MT NewswiresDec 1, 2023 13:53 ET